Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Disruption of the ERLIN–TM6SF2–APOB complex destabilizes APOB and contributes to non-alcoholic fatty liver disease
Botao Li, Ming Sun, LI Yun-feng, et al.
PLoS Genetics (2020) Vol. 16, Iss. 8, pp. e1008955-e1008955
Open Access | Times Cited: 47

Showing 1-25 of 47 citing articles:

Multi-ancestry polygenic mechanisms of type 2 diabetes
Kirk Smith, Aaron J. Deutsch, Carolyn McGrail, et al.
Nature Medicine (2024) Vol. 30, Iss. 4, pp. 1065-1074
Open Access | Times Cited: 31
VLDL Biogenesis and Secretion: It Takes a Village
Willemien van Zwol, Bart van de Sluis, Henry N. Ginsberg, et al.
Circulation Research (2024) Vol. 134, Iss. 2, pp. 226-244
Open Access | Times Cited: 21
Pla2g12b drives expansion of triglyceride-rich lipoproteins
James H. Thierer, Ombretta Foresti, Pradeep Kumar Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
TM6SF2: A Novel Genetic Player in Nonalcoholic Fatty Liver and Cardiovascular Disease
Fei Luo, Federico Oldoni, Avash Das
Hepatology Communications (2021) Vol. 6, Iss. 3, pp. 448-460
Open Access | Times Cited: 90
Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats
Fei Luo, Ēriks Šmagris, Sarah A. Martin, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 13, Iss. 3, pp. 879-899
Open Access | Times Cited: 65
Mouse models of nonalcoholic fatty liver disease (NAFLD): pathomechanisms and pharmacotherapies
Tingyu Fang, Hua Wang, Xiaoyue Pan, et al.
International Journal of Biological Sciences (2022) Vol. 18, Iss. 15, pp. 5681-5697
Open Access | Times Cited: 42
Unlocking the mysteries of VLDL: exploring its production, intracellular trafficking, and metabolism as therapeutic targets
Jingfei Chen, Zhenfei Fang, Qin Luo, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 15
Genetics of MASLD: The State of Art Update.
Silvia Sookoian, Yaron Rotman, Luca Valenti
Clinical Gastroenterology and Hepatology (2024) Vol. 22, Iss. 11, pp. 2177-2187.e3
Closed Access | Times Cited: 15
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans
Jan Borén, Martin Adiels, Elias Björnson, et al.
JCI Insight (2020) Vol. 5, Iss. 24
Open Access | Times Cited: 54
Biosynthesis and Metabolism of ApoB-Containing Lipoproteins
Jan Borén, Marja‐Riitta Taskinen, Chris J. Packard
Annual Review of Nutrition (2024) Vol. 44, Iss. 1, pp. 179-204
Closed Access | Times Cited: 7
Precision medicine and nucleotide-based therapeutics to treat MASH
Andrea Caddeo, Stefano Romeo
Clinical and Molecular Hepatology (2024)
Open Access | Times Cited: 7
Proteomics revealed composition- and size-related regulators for hepatic impairments induced by silica nanoparticles
Xinying Zhao, Ru Ma, Alimire Abulikemu, et al.
The Science of The Total Environment (2024) Vol. 922, pp. 170584-170584
Closed Access | Times Cited: 6
Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
Daryl Ramai, Waqqas Tai, Michelle Rivera, et al.
Biomedicines (2021) Vol. 9, Iss. 2, pp. 184-184
Open Access | Times Cited: 34
Lowering low-density lipoprotein cholesterol: from mechanisms to therapies
Jie Luo, Jin-Kai Wang, Bao‐Liang Song
Life Metabolism (2022) Vol. 1, Iss. 1, pp. 25-38
Open Access | Times Cited: 24
Basic and translational evidence supporting the role of TM6SF2 in VLDL metabolism
Jing Liu, Henry N. Ginsberg, Gissette Reyes‐Soffer
Current Opinion in Lipidology (2024) Vol. 35, Iss. 3, pp. 157-161
Open Access | Times Cited: 6
The Pathogenesis of HCC Driven by NASH and the Preventive and Therapeutic Effects of Natural Products
Gaoxuan Shao, Ying Liu, Lu Lu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 20
The contribution of genetics and epigenetics to MAFLD susceptibility
Vittoria Moretti, Stefano Romeo, Luca Valenti
Hepatology International (2024) Vol. 18, Iss. S2, pp. 848-860
Open Access | Times Cited: 4
ApoB SURFs a Ride from the ER to the Golgi
Henry N. Ginsberg
Cell Metabolism (2021) Vol. 33, Iss. 2, pp. 231-233
Open Access | Times Cited: 26
Mitochondrial Lipid Homeostasis at the Crossroads of Liver and Heart Diseases
Siarhei A. Dabravolski, Evgeny E. Bezsonov, Mirza S. Baig, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 6949-6949
Open Access | Times Cited: 25
Resveratrol Modulates the Redox Response and Bile Acid Metabolism to Maintain the Cholesterol Homeostasis in Fish Megalobrama amblycephala Offered a High-Carbohydrate Diet
Yaping Ge, Ling Zhang, Wei‐Liang Chen, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 121-121
Open Access | Times Cited: 10
The common p.Ile291Val variant of ERLIN1 enhances TM6SF2 function and is associated with protection against MASLD
Miriam Daphne Rendel, Cecilia Vitali, Kate Townsend Creasy, et al.
Med (2024) Vol. 5, Iss. 8, pp. 963-980.e5
Open Access | Times Cited: 3
Trans-ancestral rare variant association study with machine learning-based phenotyping for metabolic dysfunction-associated steatotic liver disease
Robert Chen, Ben Omega Petrazzini, Áine Duffy, et al.
Genome biology (2025) Vol. 26, Iss. 1
Open Access
Human genetics of metabolic dysfunction–associated steatotic liver disease: from variants to cause to precision treatment
Vincent Chen, Annapurna Kuppa, Antonino Oliveri, et al.
Journal of Clinical Investigation (2025) Vol. 135, Iss. 7
Open Access
Exploration of the potential mechanism of Baicalin for hepatic fibrosis based on network pharmacology, gut microbiota, and experimental validation
Sujie Liu, Pingping Chen, Shadi A. D. Mohammed, et al.
Frontiers in Microbiology (2023) Vol. 13
Open Access | Times Cited: 8
Interaction models matter: an efficient, flexible computational framework for model-specific investigation of epistasis
Sandra Batista, Vered Madar, Philip J. Freda, et al.
BioData Mining (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top